Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Roca Therapeutics logo — Advancing medicine to combat severe, life-threatening diseas...

Roca Therapeutics

Advancing medicine to combat severe, life-threatening diseases caused by hypervascularization and macrophage-induced immunosuppression.

Founded 2021 2-10 employees Seed Biotechnology, Health and Wellness

General Information

Company Name Roca Therapeutics
Founded Year 2021
Employees 2-10
Industries Biotechnology, Health and Wellness
Funding Stage Seed
Social

Get notified when Roca Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Roca Therapeutics

Roca Therapeutics is a biotechnology startup established in 2021, with a mission to advance the field of medicine in combatting severe, life-threatening diseases. The company's focus lies in developing small medicines targeting diseases caused by hypervascularization and the immunosuppression induced by macrophages M2. Roca Therapeutics' recent milestone includes a Seed Round investment received on 22 September 2022, with participation from 3B Future Health Fund and SATT Sud-Est. The startup operates at the intersection of the Biotechnology and Health and Wellness industries, with a unique emphasis on addressing critical medical challenges through innovative pharmaceutical solutions.

Taxonomy: Medical research, Drug development, Cancer treatment, Eye disease, Angiogenesis, Immunosuppression, Macrophage-induced diseases, Personalized therapy, Biopharmaceuticals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
22 Sep 2022

Roca Therapeutics Alternatives & Competitors

Roca Therapeutics vs
Alberta Insurance Council
Alberta Insurance Council Canada

The AIC serves to fulfill the mission of protecting Albertans through the licensing and regulation o...

68 employees
Financial Services, Insurance
Roca Therapeutics vs
German Orient-Institute
German Orient-Institute Germany

The oldest private scientific research institute on the Near and Middle East in Europe (founded by N...

4 employees
Social Media
Roca Therapeutics vs
Gwich'in Tribal Council
Gwich'in Tribal Council Canada

Gwich'in land, culture, and economy for a better future.

Grant
34 employees
Government and Military, Social Media

FAQ About Roca Therapeutics

Advancing medicine to combat severe, life-threatening diseases caused by hypervascularization and macrophage-induced immunosuppression.
Roca Therapeutics was founded in 2021.
Roca Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Roca Therapeutics has approximately 2-10 employees.
Roca Therapeutics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Roca Therapeutics include Alberta Insurance Council, German Orient-Institute, Gwich'in Tribal Council, Goshen Public Library and Historical Society, Greek Orthodox Archdiocese of America. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Roca Therapeutics and Alberta Insurance Council are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Roca Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy